Decoy Therapeutics

Want to learn more about Decoy Therapeutics? Visit our website to stay informed on our progress and updates. bit.ly/4cNEcnm $DCOY #AIDrugDiscovery #PeptideConjugates #GlobalPublicHealth #Flu #RSV #Covid #Measles #H5N1

March is Infectious Disease Awareness Month, a time to recognize the impact of viral threats worldwide. At Decoy Therapeutics, we’re focused on advancing a new category of D-MAV therapeutics for the prevention and treatment of multiple viruses. $DCOY #Flu #RSV #Covid #Measles

AI Reporter America: Decoy Therapeutics and Quantori Formed Strategic Alliance to Advance AI-Powered Peptide Engineering bit.ly/4bgrhb3 #DCOY hashtag#AIDrugDiscovery hashtag#PeptideConjugates hashtag#GlobalPublicHealth

Our Chief Scientific Officer, Barbara Hibner, highlighted how Decoy’s platform enables the integration of evolving design algorithms and models to further strengthen the company’s peptide design capabilities. Learn more: prn.to/4ujaqgJ $DCOY #AIDrugDiscovery

Our CEO, Rick Pierce, shared his perspective on our collaboration with Quantori and the use of Google Cloud’s scalable infrastructure to accelerate peptide design and expand the company’s ability to explore chemical space. Read more here: prn.to/4ujaqgJ $DCOY

Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform prn.to/4ujaqgJ $DCOY #AIDrugDiscovery #PeptideConjugates #GlobalPublicHealth

Decoy Therapeutics Announces 1-for-12 Reverse Stock Split prn.to/4lbfvTP $DCOY

Rick Pierce, CEO of Decoy Therapeutics Inc. (NASDAQ: $DCOY), joins WTR's Tim Gerdeman and Robert Sassoon to discuss Decoy’s differentiated approach to developing next-generation antivirals targeting multiple respiratory viruses. 🔹 Proprietary peptide-conjugate platform designed to address multiple viral threats with a capital-efficient development model 🔹 Rapid design-build-test cycle powered by machine learning to accelerate discovery and optimization 🔹 Strategic partnerships with the Gates Foundation, Google, and NVIDIA supporting validation and scale Listen to the full episode on all platforms or on our website! #HealthcareHappenings #Biotech #Antivirals #DrugDevelopment #MachineLearning $DCOY #HealthcareInvesting #SmallCapStocks #WaterTowerResearch

Decoy Therapeutics Joins Webull Corporate Connect Service Platform bit.ly/3MzYXIs $DCOY #AIDrugDiscovery #PeptideConjugates #GlobalPublicHealth

#StartingSoon! $DCOY will be live at 1:20pm ET during the Corporate Connect Virtual Webinar Series hosted by @webullglobal! Tune in here: bit.ly/3ZFuUCh #AIDrugDiscovery #PeptideConjugates #GlobalPublicHealth #COVID #Antiviral #Influenza #RespiratoryViruses #Peptides

#TuneInToday! Decoy takes the stage at 1:20pm ET during the Webull Corporate Connect Virtual Webinar Series! Register here: bit.ly/3ZFuUCh $DCOY #AIDrugDiscovery #PeptideConjugates #GlobalPublicHealth #COVID #Antiviral #Influenza #RespiratoryViruses #Peptides

#HappeningTomorrow We are participating in the Corporate Connect Virtual Webinar Series tomorrow, February 10, 2026 at 1:20pm ET, hosted by @WebullGlobal. Don't Miss it: bit.ly/3ZFuUCh $DCOY#AIDrugDiscovery #COVID #Antiviral #Influenza #RespiratoryViruses

#MarkYourCalendars Join us during our presentation in the Webull Corporate Connect Virtual Webinar Series on Tuesday, February 10, 2026 at 1:20pm ET. Register here: bit.ly/3ZFuUCh #AIDrugDiscovery #Peptides @WebullGlobal #COVID #Antiviral #Influenza #RespiratoryViruses

Decoy Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial on Tuesday, February 10th at 1:20 PM EST bit.ly/4anIyPo $DCOY #AIDrugDiscovery #PeptideConjugates #GlobalPublicHealth

$DCOY joined #WhatThisMeans to discuss how their manufacturing approach enables rapid scale up of peptide conjugate therapeutics from lab to production and supports a distributed global manufacturing network to address emerging viral threats. vimeo.com/1161634150/24a… @DecoyTX

Decoy Therapeutics Participates in Virtual Investor "What This Means" Segment Highlighting Recently Announced Global Access Commitment Agreement bit.ly/4qRJLVW $DCOY#AIDrugDiscovery #PeptideConjugates #GlobalPublicHealth

Decoy Therapeutics will use the platform, with funding support from the @gatesfoundation, to provide widespread access to peptide-conjugate antivirals from Decoy's IMP3ACT™ platform for low- and middle-income countries. prn.to/49RBAmp $DCOY $SLRX #AIDrugDiscovery #AIinBiotech #PeptideConjugates #COVID #Antiviral #Influenza #RespiratoryViruses #Peptides #GlobalPublicHealth

Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform prn.to/49RBAmp $DCOY $SLRX #AIDrugDiscovery #AIinBiotech #COVID #Antiviral #Influenza #RespiratoryViruses #GlobalPublicHealth

We completed our merger and are officially Decoy Therapeutics. We believe this transition positions us to move forward with clarity, focus and momentum as we execute on our vision as a unified company. Follow along with ticker $DCOY. $SLRX #AIDrugDiscovery #AIinBiotech